Presentation TCT 2016 Non-Culprit Lesion Chronic Total Occlusions in STEMI: Should We Open Them? Presenter: Ran Kornowski, Michel R. Le May, Jose P.S. Henriques October 31, 2016
Presentation TCT 2016 Primary PCI in Patients With Multivessel Disease: Overview of Randomized Trials and Unanswered Questions Presenter: Ran Kornowski, Michel R. Le May, Kevin Bainey October 31, 2016
Presentation TCT 2016 GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy Presenter: Thomas F. Luscher, Patrick W. Serruys, Francisco Fdez-Aviles October 31, 2016
Presentation TCT 2016 Egypt Presents: A Case of a High-Risk STEMI Intervention: How Did I Treat? Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari October 31, 2016
Presentation TCT 2016 TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR Presenter: Andreas Baumbach, Kurt Huber, Elmir Omerovic October 31, 2016
Presentation TCT 2016 TCT 1: Microvascular Obstruction Is Independently Associated With Adverse Events Following Primary PCI for STEMI: A Patient-Level Pooled Analysis from 7 Randomized Trials Presenter: Andreas Baumbach, Kurt Huber, Andrea Abizaid, Jun-Jack Cheng, Rajiv Gulati, Jamil Abdalla Saad October 31, 2016
Presentation TCT 2016 EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI Presenter: Joseph A. Hill, Steven P. Marso, Jose P.S. Henriques October 31, 2016
Presentation TCT 2016 TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors October 31, 2016
Presentation TCT 2016 TCT 2: Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials Presenter: Andreas Baumbach, Kurt Huber, Bjorn Redfors October 31, 2016
Presentation TCT 2016 TCT 21: Door-to-ECMO Before Door-to-Balloon? Early Implementation of ECMO Might Improve the Survival of Patients With STEMI Complicated by Refractory Cardiogenic Shock Presenter: Tanveer Rab, Richard Smalling, Chi-Cheng Huang October 31, 2016
Presentation TCT 2016 TCT 140: Explore Trial (Additional Early CTO PCI in STEMI Patients with a Concurrent CTO) and SYNTAX score. What are Lessons Learned? Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 TCT 139: A Randomized Trial of Complete Versus Culprit-Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients with Acute ST Elevation Myocardial Infarction and Multi Vessel Disease Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 TCT 138: Multivessel Versus Culprit-Only Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Analysis of a 8 Year-All-Comers Registry Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Philippines Presents a Case: Cardiogenic Shock in Non-STEMI Presenter: Rui Campante Teles, Marcelo Jose de Carvalho Cantarelli, Richard Nicandro R Torres October 30, 2016
Presentation TCT 2016 TCT 137: Influence of Nonculprit Lesions Management on Outcomes in Patients Over 75 Years Old With ST Elevated Myocardial Infarction. Results From the ESTROFA MI+75 Nationwide Registry Presenter: Warren J. Cantor, Thomas D. Stuckey October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann October 30, 2016
Presentation TCT 2016 Case Presentations: Bioresorbable Scaffolds in STEMI How to Do It Presenter: Antonio Colombo, Gary S. Mintz, Maurizio Menichelli October 30, 2016
Presentation TCT 2016 STEMI Treatment Strategies: Drugs and Devices Presenter: Tayo A. Addo, Dharam J. Kumbhani October 30, 2016